These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29405306)

  • 41. The potential of viral metagenomics in blood transfusion safety.
    Sauvage V; Gomez J; Boizeau L; Laperche S
    Transfus Clin Biol; 2017 Sep; 24(3):218-222. PubMed ID: 28694025
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fifteen years of Nucleic Acid Testing in France: Results and lessons.
    Laperche S; Tiberghien P; Roche-Longin C; Pillonel J
    Transfus Clin Biol; 2017 Sep; 24(3):182-188. PubMed ID: 28709845
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
    Nübling CM; Chudy M; Volkers P; Löwer J
    Transfusion; 2006 Nov; 46(11):1886-91. PubMed ID: 17076842
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil.
    Vieira PCM; Lamarão LM; Amaral CEM; Corrêa ASM; de Lima MSM; Barile KADS; de Almeida KLD; Sortica VA; Kayath AS; Burbano RMR
    Transfusion; 2017 Aug; 57(8):1968-1976. PubMed ID: 28589643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment.
    Keil SD; Ragan I; Yonemura S; Hartson L; Dart NK; Bowen R
    Vox Sang; 2020 Aug; 115(6):495-501. PubMed ID: 32311760
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and Treponema pallidum infections in hospitalized patients before transfusion in Xiangya hospital Central South University, China from 2011 to 2016.
    Cao WW; Zhou RR; Ou X; Shi LX; Xiao CQ; Chen TY; Tan H; Fan XG; Li BJ; Li N
    BMC Infect Dis; 2018 Apr; 18(1):145. PubMed ID: 29606088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predonation screening of candidate donors and prevention of window period donations.
    Lieshout-Krikke RW; Zaaijer HL; van de Laar TJ
    Transfusion; 2015 Feb; 55(2):373-8. PubMed ID: 25130605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Transfusion-induced virus infections: how great is the risk?].
    Sibrowski W; Penner M; Kühnl P
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():4-9. PubMed ID: 8374287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
    Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
    Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood. TTI Study Group.
    Regan FA; Hewitt P; Barbara JA; Contreras M
    BMJ; 2000 Feb; 320(7232):403-6. PubMed ID: 10669443
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Evaluation of the efficacy of medical screening of blood donors on preventing blood transfusion-transmitted infectious agents].
    Seck M; Dièye B; Guèye YB; Faye BF; Senghor AB; Toure SA; Dieng N; Sall A; Toure AO; Dièye TN; Diop S
    Transfus Clin Biol; 2016 May; 23(2):98-102. PubMed ID: 26681660
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multinational assessment of blood-borne virus testing and transfusion safety on the African continent.
    Laperche S;
    Transfusion; 2013 Apr; 53(4):816-26. PubMed ID: 22804482
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cost-effectiveness of predonation screening for transfusion transmissible infections using rapid test kits in a hospital-based blood transfusion centre.
    Dosunmu AO; Akinbami AA; Ismail AK; Olaiya MA; Uche EI; Aile IK
    Niger Postgrad Med J; 2017; 24(3):162-167. PubMed ID: 29082905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of different rapid screening tests and ELISA for HBV, HCV, and HIV among healthy blood donors and recipients at Jibla University Hospital Yemen.
    Al-Matary AM; Al Gashaa FAS
    J Med Life; 2022 Nov; 15(11):1403-1408. PubMed ID: 36567845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
    Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
    Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreasing prevalence of transfusion transmitted infection in Indian scenario.
    Chandra T; Rizvi SN; Agarwal D
    ScientificWorldJournal; 2014; 2014():173939. PubMed ID: 24616614
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
    El-Hazmi MM
    Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Red cell alloimmunization and infectious marker status (human immunodeficiency virus, hepatitis B virus and hepatitis C virus) in multiply transfused thalassemia patients of North India.
    Makroo RN; Arora JS; Chowdhry M; Bhatia A; Thakur UK; Minimol A
    Indian J Pathol Microbiol; 2013; 56(4):378-83. PubMed ID: 24441225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.